1022 related articles for article (PubMed ID: 16306937)
1. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
[TBL] [Abstract][Full Text] [Related]
2. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
Oganesyan G; Saha SK; Guo B; He JQ; Shahangian A; Zarnegar B; Perry A; Cheng G
Nature; 2006 Jan; 439(7073):208-11. PubMed ID: 16306936
[TBL] [Abstract][Full Text] [Related]
3. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
5. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
Takaoka A; Yanai H; Kondo S; Duncan G; Negishi H; Mizutani T; Kano S; Honda K; Ohba Y; Mak TW; Taniguchi T
Nature; 2005 Mar; 434(7030):243-9. PubMed ID: 15665823
[TBL] [Abstract][Full Text] [Related]
6. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.
Sasai M; Tatematsu M; Oshiumi H; Funami K; Matsumoto M; Hatakeyama S; Seya T
Mol Immunol; 2010 Mar; 47(6):1283-91. PubMed ID: 20047764
[TBL] [Abstract][Full Text] [Related]
7. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling.
Akira S; Hoshino K
J Infect Dis; 2003 Jun; 187 Suppl 2():S356-63. PubMed ID: 12792852
[TBL] [Abstract][Full Text] [Related]
8. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.
Hoebe K; Du X; Georgel P; Janssen E; Tabeta K; Kim SO; Goode J; Lin P; Mann N; Mudd S; Crozat K; Sovath S; Han J; Beutler B
Nature; 2003 Aug; 424(6950):743-8. PubMed ID: 12872135
[TBL] [Abstract][Full Text] [Related]
9. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
[TBL] [Abstract][Full Text] [Related]
10. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
[TBL] [Abstract][Full Text] [Related]
11. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
[TBL] [Abstract][Full Text] [Related]
12. TIR-containing adaptors in Toll-like receptor signalling.
Jenkins KA; Mansell A
Cytokine; 2010 Mar; 49(3):237-44. PubMed ID: 19264502
[TBL] [Abstract][Full Text] [Related]
13. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.
Liu-Bryan R; Scott P; Sydlaske A; Rose DM; Terkeltaub R
Arthritis Rheum; 2005 Sep; 52(9):2936-46. PubMed ID: 16142712
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
Youn HS; Saitoh SI; Miyake K; Hwang DH
Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
[TBL] [Abstract][Full Text] [Related]
15. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules.
Yamamoto M; Yaginuma K; Tsutsui H; Sagara J; Guan X; Seki E; Yasuda K; Yamamoto M; Akira S; Nakanishi K; Noda T; Taniguchi S
Genes Cells; 2004 Nov; 9(11):1055-67. PubMed ID: 15507117
[TBL] [Abstract][Full Text] [Related]
16. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.
Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L
Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570
[TBL] [Abstract][Full Text] [Related]
18. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes.
Hawn TR; Ozinsky A; Williams LM; Rodrigues S; Clark A; Pham U; Hill HR; Ochs H; Aderem A; Liles WC
Hum Immunol; 2005 Jul; 66(7):842-7. PubMed ID: 16112032
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.
Kawai T; Sato S; Ishii KJ; Coban C; Hemmi H; Yamamoto M; Terai K; Matsuda M; Inoue J; Uematsu S; Takeuchi O; Akira S
Nat Immunol; 2004 Oct; 5(10):1061-8. PubMed ID: 15361868
[TBL] [Abstract][Full Text] [Related]
20. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.
O'Neill LA; Bowie AG
Nat Rev Immunol; 2007 May; 7(5):353-64. PubMed ID: 17457343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
